Ozelle to Present O-Cyte 1 Hematology Analyzer at ADLM 2026

June 30, 2026
Ozelle will debut its new automated hematology analyzer, O-Cyte 1, at ADLM 2026 in California. The system uses AI to deliver morphology intelligence and scalable throughput for clinical laboratories.

Ozelle will unveil O-Cyte 1, its new automated hematology analyzer, at the upcoming Association for Diagnostics & Laboratory Medicine (ADLM) 2026 conference in Anaheim, California, announced in a press release. The device marks the company’s latest step in advancing its AI multiplied by Complete Blood Morphology technology.

O-Cyte 1 combines morphology intelligence, scalable throughput, and a compact design intended for everyday clinical workflows. The analyzer converts cell images into structured morphology data to support consistent interpretation and evidence-based analysis. It can process up to 60 tests per hour as a standalone unit and up to 360 tests per hour when connected in a cascaded configuration.

The system features modular architecture, low-maintenance operation, and a design intended to simplify laboratory processes. Ozelle plans to demonstrate O-Cyte 1 alongside its broader hematology portfolio at Booth 2517 during the ADLM 2026 event, taking place from July 28 to 30 at the Anaheim Convention Center. The company will also offer virtual briefings for partners unable to attend in person.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

06/30
One Brooklyn Health Selects hellocare.ai for AI Assisted Virtual Care Across Hospitals
06/30
Xellar Biosystems Raises $50 Million to Expand 3D Bio Intelligence Platform
06/29
4DMedical Gains TGA Approval for CT:VQ Lung Imaging in Australia
06/27
RADIN Health Expands Platform to Four More UHS Nevada Hospitals
06/26
UpDoc Receives FDA Clearance for Clinical AI Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like